Test Price
1,300 AED✅ Home Collection Available
ONCOPRO EGFR ARMS PCR Test – DHA Licensed Molecular Oncology Assay in Dubai, UAE
Executive Summary & Core Metrics
Diagnostic Sensitivity: 99.9% – detects low-abundance EGFR mutations down to 1% allele frequency via allele-specific real-time PCR (ARMS) integrated with whole-genome sequencing (WGS).
Specimen Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval – formalin-fixed paraffin-embedded (FFPE) blocks transported under ambient chain-of-custody protocols. Mobile phlebotomy is disabled for this archival tissue category.
Turnaround Time: 4 working days when the FFPE block arrives by Monday 11:00 AM.
Insurance: Direct billing verification available via WhatsApp +971 54 548 8731.
Accreditation: ISO 9001:2015 Certified – Cert: INT/EGQ/2509DA/3139.
Test Overview & Methodology
The ONCOPRO EGFR ARMS PCR Test combines allele-specific real-time PCR (ARMS) with whole-genome sequencing (WGS) to detect clinically actionable EGFR mutations in non-small-cell lung cancer (NSCLC). The assay identifies sensitising mutations (exon 19 deletions, L858R) and resistance mutations (T790M, C797S) in formalin-fixed paraffin-embedded (FFPE) tumour tissue. Results guide tyrosine-kinase inhibitor (TKI) selection and enable oncologists to tailor targeted therapy with high precision.
| Feature | ONCOPRO EGFR ARMS PCR | Closest Alternative |
|---|---|---|
| Methodology | ARMS-PCR + Whole-Genome Sequencing (WGS) | Sanger Sequencing or Single-Gene PCR |
| Diagnostic Sensitivity | 99.9% – detects low-abundance mutations down to 1% allele frequency | ~95% – limited sensitivity for low-level mutant DNA |
| Turnaround Time | 4 working days (sample received by Monday 11:00 AM) | 7–10 working days |
| Price (AED) | 1,300 AED | 1,100–1,500 AED |
Physician Insight & Safety Protocols
“Awaiting genomic test results can be a period of heightened anxiety for patients and their families. This integrated ARMS-PCR and WGS panel uncovers clinically actionable EGFR mutations that inform targeted therapy selection. However, the molecular findings must always be correlated with full histopathology, cross-sectional imaging, and a comprehensive clinical assessment. A multidisciplinary tumour board review remains the gold standard for personalising the treatment plan.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Clinical Advisory – Medication Continuity
Patients must not discontinue or modify any prescribed medication, including tyrosine-kinase inhibitors or other anticancer therapies, without direct consultation with their treating oncologist. Abrupt cessation of targeted therapy can lead to accelerated disease progression and adverse clinical outcomes.
Safety Exclusions & Specimen Rejection Criteria
- FFPE block with <10% tumour cell content – insufficient neoplastic cellularity for reliable mutation detection.
- Decalcified bone biopsies – DNA integrity may be severely compromised.
- FFPE blocks archived more than 5 years – progressive DNA crosslinking reduces amplifiable template yield.
- Emergency Red Flags: Seek immediate medical attention if you experience acute chest pain, severe dyspnoea, haemoptysis, or any sudden deterioration in clinical status unrelated to the testing procedure.
Patient FAQ & Clinical Guidance
1. What is the ONCOPRO EGFR ARMS PCR Test used for?
This test detects activating and resistance mutations in the EGFR gene of non-small-cell lung cancer tumours using a highly sensitive allele-specific PCR method combined with whole-genome sequencing. Identifying mutations such as exon 19 deletions, L858R, and T790M allows your oncologist to select the most effective tyrosine-kinase inhibitor (TKI) therapy tailored to your tumour's molecular profile.
2. What sample type is required and how is it collected?
The test requires a formalin-fixed paraffin-embedded (FFPE) tissue block containing at least 10% tumour cells. The block is retrieved from the hospital pathology archive and transported via Secure Medical Courier under ambient temperature. Home phlebotomy is not applicable for this specimen category. Insufficient tumour content or decalcified specimens will be rejected to preserve diagnostic accuracy.
3. How quickly will I receive my results?
Results are delivered within 4 working days when the FFPE block is received by Monday 11:00 AM. The integrated ARMS-PCR and WGS workflow enables rapid turnaround. Reports are issued as encrypted PDFs and notified via WhatsApp on the same day they become available.
4. Will my health insurance cover the cost of this test?
Coverage varies by insurer and policy. Our team can verify your direct billing eligibility via WhatsApp at +971 54 548 8731. We recommend contacting your insurance provider to confirm pre-authorisation requirements before sample submission.
5. How should I interpret a positive EGFR mutation result?
A positive result indicates the presence of one or more EGFR mutations that are associated with response or resistance to specific TKIs. Your oncologist will correlate this molecular information with your histopathology, imaging, and overall clinical status during a multidisciplinary tumour board review to formulate an individualised treatment strategy. Do not alter your current therapy based solely on a laboratory report.
UAE Regulatory & Data Privacy Adherence
Legal & Compliance Framework
This laboratory service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All genomic data is encrypted, access-controlled, and processed exclusively within UAE infrastructure. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | ONCOPRO EGFR ARMS PCR |
| Price (AED) | 1,300 AED |
| Turnaround Time | 4 Working Days (Sample Received by Monday 11:00 AM) |
| Sample Type / Matrix | Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block – Secure Medical Courier Solid Tissue Specimen Retrieval |
| Methodology Used | Allele-Specific Real-Time PCR (ARMS) + Whole-Genome Sequencing (WGS) |
| ICD-10-CM Code | C34.90 |
| LOINC Code | 82989-2 |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians